US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 4.270
  • -0.040-0.93%
Close Jul 19 16:00 ET
486.06MMarket Cap-2223P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-96.74%1.93M
-34.03%63.53M
-96.22%1.68M
-87.02%1.94M
-94.97%933K
220.30%58.98M
72.44%96.3M
159.86%44.36M
5.31%14.98M
38.30%18.55M
Operating revenue
-96.74%1.93M
-34.03%63.53M
-96.22%1.68M
-87.02%1.94M
-94.97%933K
220.30%58.98M
72.44%96.3M
159.86%44.36M
5.31%14.98M
38.30%18.55M
Cost of revenue
Gross profit
Operating expense
-39.49%52.99M
-37.22%254.04M
-54.26%49.75M
-47.50%53.22M
-37.54%63.5M
-5.72%87.57M
48.32%404.69M
25.82%108.78M
47.24%101.37M
68.89%101.66M
Selling and administrative expenses
-4.96%20.86M
-3.31%81.45M
-16.91%17.94M
-12.09%18.95M
11.16%22.62M
5.79%21.94M
46.95%84.23M
27.44%21.58M
37.14%21.56M
67.25%20.35M
-General and administrative expense
-4.96%20.86M
-3.31%81.45M
-16.91%17.94M
-12.09%18.95M
11.16%22.62M
5.79%21.94M
46.95%84.23M
27.44%21.58M
37.14%21.56M
67.25%20.35M
Research and development costs
-51.03%32.14M
-46.14%172.6M
-63.51%31.82M
-57.06%34.28M
-49.73%40.88M
-9.02%65.63M
48.69%320.45M
25.43%87.19M
50.23%79.82M
69.31%81.31M
Operating profit
-78.61%-51.07M
38.22%-190.51M
25.37%-48.08M
40.64%-51.28M
24.72%-62.57M
61.60%-28.59M
-42.12%-308.39M
7.15%-64.42M
-58.16%-86.39M
-77.66%-83.11M
Net non-operating interest income expense
12.32%4.15M
194.18%17.19M
53.26%4.41M
162.84%4.7M
478.73%4.38M
783.73%3.69M
346.29%5.84M
869.70%2.88M
518.34%1.79M
118.79%757K
Non-operating interest income
12.32%4.15M
194.18%17.19M
53.26%4.41M
162.84%4.7M
478.73%4.38M
783.73%3.69M
346.29%5.84M
869.70%2.88M
518.34%1.79M
118.79%757K
Other net income (expense)
-118.03%-1.09M
-40.46%12.4M
-108.91%-461K
35.64%1.41M
-13.09%5.43M
-28.02%6.02M
489.22%20.82M
1,015.52%5.18M
-90.56%1.04M
171.80%6.25M
Gain on sale of security
----
-87.62%2.52M
----
----
----
----
474.62%20.31M
----
----
----
Other non- operating income (expenses)
-118.03%-1.09M
1,815.12%9.88M
80.33%-2.98M
35.64%1.41M
-13.09%5.43M
-28.02%6.02M
--516K
---15.13M
-90.56%1.04M
171.80%6.25M
Income before tax
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
Income tax
Net income
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
Net income continuous Operations
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
Minority interest income
Net income attributable to the parent company
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
Basic earnings per share
-147.37%-0.47
43.64%-1.64
22.41%-0.45
46.51%-0.46
31.65%-0.54
72.06%-0.19
-29.91%-2.91
19.44%-0.58
-91.11%-0.86
-36.21%-0.79
Diluted earnings per share
-147.37%-0.47
43.64%-1.64
22.41%-0.45
46.51%-0.46
31.65%-0.54
72.06%-0.19
-29.91%-2.91
19.44%-0.58
-91.11%-0.86
-36.21%-0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -96.74%1.93M-34.03%63.53M-96.22%1.68M-87.02%1.94M-94.97%933K220.30%58.98M72.44%96.3M159.86%44.36M5.31%14.98M38.30%18.55M
Operating revenue -96.74%1.93M-34.03%63.53M-96.22%1.68M-87.02%1.94M-94.97%933K220.30%58.98M72.44%96.3M159.86%44.36M5.31%14.98M38.30%18.55M
Cost of revenue
Gross profit
Operating expense -39.49%52.99M-37.22%254.04M-54.26%49.75M-47.50%53.22M-37.54%63.5M-5.72%87.57M48.32%404.69M25.82%108.78M47.24%101.37M68.89%101.66M
Selling and administrative expenses -4.96%20.86M-3.31%81.45M-16.91%17.94M-12.09%18.95M11.16%22.62M5.79%21.94M46.95%84.23M27.44%21.58M37.14%21.56M67.25%20.35M
-General and administrative expense -4.96%20.86M-3.31%81.45M-16.91%17.94M-12.09%18.95M11.16%22.62M5.79%21.94M46.95%84.23M27.44%21.58M37.14%21.56M67.25%20.35M
Research and development costs -51.03%32.14M-46.14%172.6M-63.51%31.82M-57.06%34.28M-49.73%40.88M-9.02%65.63M48.69%320.45M25.43%87.19M50.23%79.82M69.31%81.31M
Operating profit -78.61%-51.07M38.22%-190.51M25.37%-48.08M40.64%-51.28M24.72%-62.57M61.60%-28.59M-42.12%-308.39M7.15%-64.42M-58.16%-86.39M-77.66%-83.11M
Net non-operating interest income expense 12.32%4.15M194.18%17.19M53.26%4.41M162.84%4.7M478.73%4.38M783.73%3.69M346.29%5.84M869.70%2.88M518.34%1.79M118.79%757K
Non-operating interest income 12.32%4.15M194.18%17.19M53.26%4.41M162.84%4.7M478.73%4.38M783.73%3.69M346.29%5.84M869.70%2.88M518.34%1.79M118.79%757K
Other net income (expense) -118.03%-1.09M-40.46%12.4M-108.91%-461K35.64%1.41M-13.09%5.43M-28.02%6.02M489.22%20.82M1,015.52%5.18M-90.56%1.04M171.80%6.25M
Gain on sale of security -----87.62%2.52M----------------474.62%20.31M------------
Other non- operating income (expenses) -118.03%-1.09M1,815.12%9.88M80.33%-2.98M35.64%1.41M-13.09%5.43M-28.02%6.02M--516K---15.13M-90.56%1.04M171.80%6.25M
Income before tax -154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M-92.95%-83.56M-38.04%-76.11M
Income tax
Net income -154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M-92.95%-83.56M-38.04%-76.11M
Net income continuous Operations -154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M-92.95%-83.56M-38.04%-76.11M
Minority interest income
Net income attributable to the parent company -154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M-92.95%-83.56M-38.04%-76.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M-92.95%-83.56M-38.04%-76.11M
Basic earnings per share -147.37%-0.4743.64%-1.6422.41%-0.4546.51%-0.4631.65%-0.5472.06%-0.19-29.91%-2.9119.44%-0.58-91.11%-0.86-36.21%-0.79
Diluted earnings per share -147.37%-0.4743.64%-1.6422.41%-0.4546.51%-0.4631.65%-0.5472.06%-0.19-29.91%-2.9119.44%-0.58-91.11%-0.86-36.21%-0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg